Results 31 to 40 of about 192,885 (309)

Management of triple negative breast cancer

The Breast, 2010
Triple negative breast cancer (TNBC) accounts for approximately 15% of breast cancer cases. TNBC is an immunohistochemically defined subtype, with significant diversity within the subtype. Generally TNBC occurs in younger women and is marked by high rates of relapse, visceral and CNS metastases, and early death.
C. Oakman, G. Viale, A. Di Leo
openaire   +3 more sources

Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer [PDF]

, 2015
PURPOSE: This study aimed to evaluate the survival benefit of different adjuvant chemotherapy regimens in patients with T1-2N0 triple-negative breast cancer.
박세호
core   +1 more source

A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway [PDF]

Einstein (São Paulo)
Introduction Triple-negative breast cancer is an aggressive subtype of breast cancer characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression. This phenotype renders triple-negative
Isabele Pardo, Pedro Brecheret Fagundes, Rafael Santana de Oliveira, Paulo Vidal Campregher   +3 more
doaj   +1 more source

GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines [PDF]

, 2011
Breakthrough Breast CancerBackground: Gonadotrophin releasing hormone (GnRH) analogs lower estrogen levels in pre-menopausal breast cancer patients. GnRH receptor (GnRH-R) activation also directly inhibits the growth of certain cells.
Sims Andrew H, Faratian Dana, Miller, Nicola, Sims, Andrew H., Morgan, Kevin, Miller Nicola, Millar, Robert P., Langdon, Simon P., Ilgin Cagnan, Sims, Andrew, Dana Faratian, Robert P Millar, Meyer, Colette, Simon P Langdon, Colette Meyer, Harrison David J, Cagnan, Ilgin, Nicola Miller, Morgan Kevin, Millar Robert P, David J Harrison, Faratian, Dana, Langdon Simon P, Kevin Morgan, Meyer Colette, Cagnan Ilgin, Andrew H Sims, Harrison, David J.   +27 more
core   +1 more source

Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models [PDF]

, 2015
This research was financed in part by a Grant of the 7th Framework Program of the European Union (METOXIA project; HEALTH‐F2‐2009‐222741) and the NGI Pre- Seed grant (NWO n° 93613002).Triple negative, resistant or metastatic disease are major factors in ...
Kunkler, Ian H., Jarman, Edward J, Kunkler, Ian, Pavathaneni, Nanda- Kumar, Meehan, James, Jarman, Edward, Ward, Carol, Harrison, David James, Langdon, Simon P., Dixon, J. Michael, Um, In Hwa, Supuran, Claudiu, Lambin, Philippe, Winum, Jean-Yves, Um, Inhwa, Dixon, MIchael, Supuran, Claudiu Trandafir, Renshaw, Lorna, Harrison, David J, Dubois, Ludwig, Langdon, Simon, Thomas, Jeremy, Mullen, Peter, Kay, Charlene, Jarman, Edward J., Kay, Charlene; id_orcid, Supuran, Claudiu T, Harrison, David, Pavathaneni, Nanda-Kumar, Thomas, Jeremy S., Harrison, David J.   +30 more
core   +1 more source

Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin

Breast Cancer: Basic and Clinical Research, 2009
In the current study, we sought to examine the effects of curcumin in a specific type of breast cancer called triple negative breast cancer. These cancers lack expression of the estrogen and progesterone receptors and do not over-express HER2.
Danica L. Rowe, Tuba Ozbay, Ruth M. O'Regan, Rita Nahta   +3 more
doaj   +2 more sources

FA2H Exhibits Tumor Suppressive Roles on Breast Cancers via Cancer Stemness Control

Frontiers in Oncology, 2019
Background: Triple negative breast cancers are aggressive, enriched with cancer stem cells, and lack effective targeted therapies with little side effects.Methods: We isolated cancer stem cells from two triple negative breast cancer cell lines via cell ...
Xiaofeng Dai, Shuo Zhang, Hongye Cheng, Dongyan Cai, Dongyan Cai, Xiao Chen, Zhaohui Huang, Zhaohui Huang   +7 more
doaj   +1 more source

Efficacy and selectivity of tumor-treating field therapy for triple-negative breast cancer cells via in-house delivery device

Discover Oncology, 2023
Purpose Triple-negative breast cancer continues to be one of the leading causes of death in women, making up 7% of all cancer deaths. Tumor-treating electric fields are low-energy, low-frequency oscillating electric fields that induce an anti ...
Austin R. Smothers, Jason R. Henderson, John J. O’Connell, Jonathan M. Stenbeck, Delphine Dean, Tyler G. Harvey, Brian W. Booth   +6 more
doaj   +1 more source

Radiological diagnostics of triple negative breast cancer: a review

Acta Medica Lituanica, 2011
Background. Triple negative breast cancer has a poor prognosis. Therefore, it is vital to detect this subtype of breast cancer in its early stage. The imaging features of this clinically important subtype of breast cancer are not well known.
Sigutė STADALNYKAITĖ, Rūta BRIEDIENĖ
doaj   +1 more source

The Omics of Triple-Negative Breast Cancers [PDF]

Clinical Chemistry, 2014
Abstract BACKGROUND Triple-negative breast cancers (TNBC) do not represent a single disease subgroup and are often aggressive breast cancers with poor prognoses. Unlike estrogen/progesterone receptor and HER2 (human epidermal growth factor receptor 2) breast cancers, which are responsive to targeted ...
Hong, Xu, Peter, Eirew, Sarah C, Mullaly, Samuel, Aparicio   +3 more
openaire   +2 more sources